May 2019

FIRST MEDICINAL CANNABIS TRIAL TO TREAT TOURETTE’S SYNDROME BRINGS HOPE TO AUSTRALIAN PATIENTS

Chris Wright, Brisbane local who was diagnosed with Tourette’s syndrome at the age of 12 is one of the first patients recruited for the trial run by Brisbane’s Wesley Medical Research. The trial aims to assess the effects of medicinal cannabis on symptoms such as uncontrollable physical and/or verbal ticks. Read the article here.

ANTG’s James Gaskell joins 2SER Breakfast on 107.3 to discuss his thoughts on ACT’s recent legalisation of cannabis, the conflict of state vs federal laws, and the medicinal cannabis industry in Australia and abroad.

READ MORE >

In the first 12 months we expect to see two tonnes plus in export. Exportation will begin to Germany, where we have signed a 10-year supply contract with Cannamedical Pharma.

READ MORE >

A report into the Narcotic Drugs Act (ND Act) has recommended several changes to medical cannabis regulation in Australia.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >